Richard A.J. Darby
Overcoming ABCG2-mediated drug resistance with imidazo-[1,2-b]-pyridazine-based Pim1 kinase inhibitors
Darby, Richard A.J.; Kerr, Ian; Unsworth, Amanda; Knapp, Stefan; Callaghan, Richard
Authors
IAN KERR ian.kerr@nottingham.ac.uk
Associate Professor
Amanda Unsworth
Stefan Knapp
Richard Callaghan
Abstract
Purpose
Multidrug efflux pumps such as ABCG2 confer drug resistance to a number of cancer types, leading to poor prognosis and outcome. To date, the strategy of directly inhibiting multidrug efflux pumps in order to overcome drug resistance in cancer has been unsuccessful. An alternative strategy is to target proteins involved in the regulation of multidrug efflux pump activity or expression. Pim1 kinase has been demonstrated to phosphorylate ABCG2, promote its oligomerisation and contribute to its ability to confer drug resistance.
Methods
In the present manuscript, imidazo-pyridazine-based inhibitors of Pim1 were examined for their ability to overcome ABCG2-mediated drug resistance. Drug efficacy was measured as a cytotoxic response or an effect on transport by ABCG2. Protein expression patterns were assessed using western immuno-blotting.
Results
The two Pim1 inhibitors increased the potency of flavopiridol, mitoxantrone, topotecan and doxorubicin, specifically in ABCG2-expressing cells. This effect was associated with an increase in the cellular accumulation of [3H]-mitoxantrone, suggesting direct impairment of the transporter. However, prolonged pre-incubation with the studied inhibitors greatly enhanced the effect on mitoxantrone accumulation. The inhibitors caused a significant time-dependent reduction in the expression of ABCG2 in the resistant cells, an effect that would improve drug efficacy.
Conclusion
Consequently, it appears that the Pim1 inhibitors display a dual-mode effect on ABCG2-expressing cancer cells. This may provide a powerful new strategy in overcoming drug resistance by targeting proteins that regulate expression of efflux pumps.
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 25, 2015 |
Publication Date | Oct 1, 2015 |
Deposit Date | Sep 29, 2017 |
Print ISSN | 0344-5704 |
Electronic ISSN | 1432-0843 |
Publisher | BMC |
Peer Reviewed | Peer Reviewed |
Volume | 76 |
Issue | 4 |
Pages | 853-864 |
DOI | https://doi.org/10.1007/s00280-015-2858-9 |
Public URL | https://nottingham-repository.worktribe.com/output/1107701 |
Publisher URL | https://link.springer.com/article/10.1007%2Fs00280-015-2858-9 |
PMID | 00036149 |
Additional Information | eStaffProfile Description: , eStaffProfile Brief Description of Type: |
You might also like
Dimerization of ABCG2 analysed by bimolecular fluorescence complementation
(2011)
Journal Article
Long-term exposure to irinotecan reduces cell migration in glioma cells.
(2016)
Journal Article
The multidrug transporter ABCG2: still more questions than answers
(2016)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search